SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-000733
Filing Date
2024-01-02
Accepted
2024-01-02 16:51:00
Documents
13
Period of Report
2023-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d699994d8k.htm   iXBRL 8-K 36096
2 EX-10.1 d699994dex101.htm EX-10.1 2661852
  Complete submission text file 0001193125-24-000733.txt   3368997

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA endp-20231228.xsd EX-101.SCH 2498
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE endp-20231228_lab.xml EX-101.LAB 15748
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endp-20231228_pre.xml EX-101.PRE 9900
7 EXTRACTED XBRL INSTANCE DOCUMENT d699994d8k_htm.xml XML 3169
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 24503211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)